XML 14 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Current Assets:    
Cash $ 25,000 $ 25,000
Prepaid expenses 482,069
Total current assets 507,069 25,000
Deferred offering costs associated with the initial public offering 180,805
Other assets 64,562
Cash equivalents held in Trust Account 300,023,016
Total Assets 300,594,647 205,805
Current Liabilities:    
Accrued expenses 1,316,833 76,294
Payables to related party 557,123 105,805
Sponsor loan - promissory notes 949,154
Franchise tax payable 200,000
Total Current Liabilities 3,023,110 182,099
Warrant liability 19,954,232
FPS liability 4,452,968
Total Liabilities 27,430,310 182,099
Commitments and Contingencies
Class A common stock subject to possible redemption, 30,000,000 and 0 shares issued and outstanding at redemption value of $10.00 per share as of December 31, 2021 and 2020, respectively 300,000,000
Stockholders’ Equity (Deficit):    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding as of both December 31, 2021 and, 2020
Class A common stock, $0.0001 par value; 160,000,000 shares authorized; 700,000 shares issued and outstanding (excluding 30,000,000 shares subject to possible redemption) as of December 31, 2021 and no shares issued or outstanding as of December 31, 2020 70
Class B common stock, $0.0001 par value; 40,000,000 shares authorized; 7,500,000 and 8,625,000(1) shares issued and outstanding as of December 31, 2021 and, 2020, respectively 750 863
Additional paid-in capital 160,975 24,137
Accumulated deficit (26,997,458) (1,294)
Total Stockholders’ Equity (Deficit) (26,835,663) 23,706
Total Liabilities and Stockholders’ Equity (Deficit) $ 300,594,647 $ 205,805